117 related articles for article (PubMed ID: 12403453)
1. Apoptotic response to photodynamic therapy versus the Bcl-2 antagonist HA14-1.
Kessel D; Castelli M; Reiners JJ
Photochem Photobiol; 2002 Sep; 76(3):314-9. PubMed ID: 12403453
[TBL] [Abstract][Full Text] [Related]
2. The Bcl-2 antagonist HA14-1 forms a fluorescent albumin complex that can be mistaken for several oxidized ROS probes.
Kessel D; Price M; Reiners JJ
Photochem Photobiol; 2008; 84(5):1272-6. PubMed ID: 18513234
[TBL] [Abstract][Full Text] [Related]
3. The small organic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death.
Manero F; Gautier F; Gallenne T; Cauquil N; Grée D; Cartron PF; Geneste O; Grée R; Vallette FM; Juin P
Cancer Res; 2006 Mar; 66(5):2757-64. PubMed ID: 16510597
[TBL] [Abstract][Full Text] [Related]
4. Ethyl-2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H- chromene-3-carboxylate (HA 14-1), a prototype small-molecule antagonist against antiapoptotic Bcl-2 proteins, decomposes to generate reactive oxygen species that induce apoptosis.
Doshi JM; Tian D; Xing C
Mol Pharm; 2007; 4(6):919-28. PubMed ID: 17874842
[TBL] [Abstract][Full Text] [Related]
5. Promotion of PDT efficacy by a Bcl-2 antagonist.
Kessel D
Photochem Photobiol; 2008; 84(3):809-14. PubMed ID: 18179619
[TBL] [Abstract][Full Text] [Related]
6. Critical upstream signals of cytochrome C release induced by a novel Bcl-2 inhibitor.
An J; Chen Y; Huang Z
J Biol Chem; 2004 Apr; 279(18):19133-40. PubMed ID: 14966123
[TBL] [Abstract][Full Text] [Related]
7. The apoptotic effect of HA14-1, a Bcl-2-interacting small molecular compound, requires Bax translocation and is enhanced by PK11195.
Chen J; Freeman A; Liu J; Dai Q; Lee RM
Mol Cancer Ther; 2002 Oct; 1(12):961-7. PubMed ID: 12481420
[TBL] [Abstract][Full Text] [Related]
8. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H
Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
[TBL] [Abstract][Full Text] [Related]
9. A mechanism for the proapoptotic activity of ursodeoxycholic acid: effects on Bcl-2 conformation.
Castelli M; Reiners JJ; Kessel D
Cell Death Differ; 2004 Aug; 11(8):906-14. PubMed ID: 15258617
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer.
Doshi JM; Tian D; Xing C
J Med Chem; 2006 Dec; 49(26):7731-9. PubMed ID: 17181155
[TBL] [Abstract][Full Text] [Related]
11. Ceramide response post-photodamage is absent after treatment with HA14-1.
Separovic D; Wang S; Awad Maitah MY; Hanada K; Kessel D
Biochem Biophys Res Commun; 2006 Jun; 345(2):803-8. PubMed ID: 16701558
[TBL] [Abstract][Full Text] [Related]
12. Initiation of apoptosis and autophagy by the Bcl-2 antagonist HA14-1.
Kessel D; Reiners JJ
Cancer Lett; 2007 May; 249(2):294-9. PubMed ID: 17055152
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells.
Campàs C; Cosialls AM; Barragán M; Iglesias-Serret D; Santidrián AF; Coll-Mulet L; de Frias M; Domingo A; Pons G; Gil J
Exp Hematol; 2006 Dec; 34(12):1663-9. PubMed ID: 17157163
[TBL] [Abstract][Full Text] [Related]
14. Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor.
An J; Chervin AS; Nie A; Ducoff HS; Huang Z
Oncogene; 2007 Feb; 26(5):652-61. PubMed ID: 16909121
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric analysis of HA14-1-induced apoptosis in follicular lymphoma cells.
Wlodkowic D; Skommer J; Pelkonen J
Leuk Res; 2006 Sep; 30(9):1187-92. PubMed ID: 16414117
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2 inhibitors sensitize tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by uncoupling of mitochondrial respiration in human leukemic CEM cells.
Hao JH; Yu M; Liu FT; Newland AC; Jia L
Cancer Res; 2004 May; 64(10):3607-16. PubMed ID: 15150119
[TBL] [Abstract][Full Text] [Related]
17. HA14-1, a small molecule inhibitor of Bcl-2, bypasses chemoresistance in leukaemia cells.
Oliver L; Mahé B; Gréé R; Vallette FM; Juin P
Leuk Res; 2007 Jun; 31(6):859-63. PubMed ID: 17224180
[TBL] [Abstract][Full Text] [Related]
18. Effect of HA14-1 on apoptosis-regulating proteins in HeLa cells.
Rehman K; Tariq M; Akash MS; Gillani Z; Qazi MH
Chem Biol Drug Des; 2014 Mar; 83(3):317-23. PubMed ID: 24118733
[TBL] [Abstract][Full Text] [Related]
19. Sphingomyelins suppress the targeted disruption of lysosomes/endosomes by the photosensitizer NPe6 during photodynamic therapy.
Caruso JA; Mathieu PA; Reiners JJ
Biochem J; 2005 Dec; 392(Pt 2):325-34. PubMed ID: 15943580
[TBL] [Abstract][Full Text] [Related]
20. Regulation of HA14-1 mediated oxidative stress, toxic response, and autophagy by curcumin to enhance apoptotic activity in human embryonic kidney cells.
Ranjan K; Sharma A; Surolia A; Pathak C
Biofactors; 2014; 40(1):157-69. PubMed ID: 23559532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
